Work

Tyrosine Kinase Inhibitors with or without Donor Lymphocyte Infusion Continue to Provide Long-Term Survival after Relapse of Chronic Myeloid Leukemia Following Hematopoietic Cell Transplantation

Year: 2018

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2018-99-118918

Authors: Sarah Ann Schmidt, Jennifer Holter Chakrabarty, Ying Liu, Zhen-Huan Hu, Kirsten M. Williams, Edwin P. Alyea, Uday Popat, Ronald Sobecks, Bart L Scott, Wael Saber

Institutions: University of Oklahoma, Medical College of Wisconsin, Children's National, Dana-Farber Cancer Institute, The University of Texas MD Anderson Cancer Center, Cleveland Clinic, Fred Hutch Cancer Center

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2905734326

Cites:

Cited by:

Related to: 10